I completed my PhD in Molecular Medicine at the University of Sheffield, in which I investigated the
role of growth hormone-induced JAK/STAT signalling in polycystic kidney disease, using small
molecule inhibitors to prevent disease progression.
I am currently a Postdoctoral Research Associate at Queen Mary University of London, supervised by
Dr Maria Fragiadaki. My primary research focuses on the role of RNA binding proteins in polycystic
kidney disease, specifically the contribution of the RNA binding protein ANKHD1 towards
pathogenesis and progression of cyst development.